tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
查看詳細走勢圖
62.855USD
+0.435+0.70%
收盤 12/26, 16:00美東報價延遲15分鐘
3.02B總市值
15.48本益比TTM

Prestige Consumer Healthcare Inc

62.855
+0.435+0.70%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.70%

5天

+1.48%

1月

+6.52%

6月

-23.10%

今年開始到現在

-19.51%

1年

-20.18%

查看詳細走勢圖

操作建議

Prestige Consumer Healthcare Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名7/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價77.50。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Prestige Consumer Healthcare Inc評分

相關信息

行業排名
7 / 158
全市場排名
21 / 4562
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 6 分析師
買入
評級
77.500
目標均價
+28.50%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Prestige Consumer Healthcare Inc亮點

亮點風險
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
估值合理
公司最新PE估值15.37,處於3年歷史合理位
機構減倉
最新機構持股52.11M股,環比減少3.75%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉190.00股
活躍度增加
近期活躍度增加,過去20天平均換手率1.12

Prestige Consumer Healthcare Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Prestige Consumer Healthcare Inc簡介

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
公司代碼PBH
公司Prestige Consumer Healthcare Inc
CEOLombardi (Ronald M)
網址https://www.prestigebrands.com/

常見問題

Prestige Consumer Healthcare Inc(PBH)的當前股價是多少?

Prestige Consumer Healthcare Inc(PBH)的當前股價是 62.855。

Prestige Consumer Healthcare Inc 的股票代碼是什麼?

Prestige Consumer Healthcare Inc的股票代碼是PBH。

Prestige Consumer Healthcare Inc股票的52週最高點是多少?

Prestige Consumer Healthcare Inc股票的52週最高點是90.040。

Prestige Consumer Healthcare Inc股票的52週最低點是多少?

Prestige Consumer Healthcare Inc股票的52週最低點是57.250。

Prestige Consumer Healthcare Inc的市值是多少?

Prestige Consumer Healthcare Inc的市值是3.02B。

Prestige Consumer Healthcare Inc的淨利潤是多少?

Prestige Consumer Healthcare Inc的淨利潤為214.60M。

現在Prestige Consumer Healthcare Inc(PBH)的股票是買入、持有還是賣出?

根據分析師評級,Prestige Consumer Healthcare Inc(PBH)的總體評級為買入,目標價格為77.500。

Prestige Consumer Healthcare Inc(PBH)股票的每股收益(EPS TTM)是多少

Prestige Consumer Healthcare Inc(PBH)股票的每股收益(EPS TTM)是4.061。
KeyAI